drugset / Trial / NCT00004658
Phase II Study of Ribose, Uridine, and Thymidine for a Complex Syndrome Involving Excessive 5'-Nucleotidase Activity
Phase 2
Completed
National Center for Research Resources (NCRR)
University of California, San Diego · collab
Treatment
Summary
OBJECTIVES: I. Evaluate the efficacy of oral ribose in patients with a complex 5'-nucleotidase syndrome who have not received uridine (UR) and thymidine (TDR). II. Evaluate the efficacy of UR/oral ribose and UR/TDR. III. Evaluate the efficacy of oral ribose given in combination with UR/TDR.
Timeline
- Start
- 1995-03
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Thymidine | Unknown | — | — |
| Subject | Uridine | Small molecule | — | — |
| Subject | ribose | Unknown | — | Oral |